Skip to main content

Table 3 Univariate analysis relationship between factors and survival

From: Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer

Variable

Hazard Ratio (95%) CI

p value

Sex

1.163 (0.734–1.843)

0.519

Age

1.091 (0.699–1.704)

0.702

Tumour Differentiation

1.398 (0.879–2.224)

0.157

Tumor Stage

2.805 (1.749–4.499)

< 0.001

Tumor location

1.102 (0.652–1.864)

0.716

Tumor Size

0.938 (0.587–1.499)

0.788

Metastasis status

9.482 (2.156–41.707)

0.003

Lymph Node Involvement

2.029 (1.292–3.188)

0.002

Vascular invastion

1.04 (0.659–1.64)

0.868

Transgelin2 p-S145

2.27 (1.42–3.627)

0.001

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us